Tag: Prescription Drugs
Factors Examined for Time to First Rx for Biologic DMARD in RA
Longer time to receipt more likely with older age, male sex, greater distance to nearest rheumatologist
SABCS: Addition of Tucatinib Ups Survival in HER2+ Metastatic Breast Cancer
In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression-free survival
ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma
Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT
Many With Diabetes Engage in Underground Exchange of Medications, Supplies
Diabetes-specific financial stress predicts engagement in trading, receiving donated meds, supplies
Pharmacist-Led Interventions Cut Cardiovascular Risk Factors
Interventions associated with drops in blood pressure, cholesterol, HbA1c
Retail Prescription Drug Prices Fall for First Time in 45 Years
Decrease due to drops in generic drug prices and slow growth in the cost of brand-name medications
FDA Testing Levels of Carcinogen in Diabetes Drug Metformin
No metformin recalls affect U.S. market at the moment
First-Line Osimertinib May Up Survival in EGFR-Mutated NSCLC
For previously untreated disease, overall survival longer with osimertinib versus comparator EGFR-TKIs
Ubrogepant Relieves Pain, Symptoms of Acute Migraine
More patients receiving ubrogepant 50 mg, 100 mg versus placebo report freedom from pain at two hours
New HIV Infections Remained Stable in U.S. From 2013 to 2017
Of the 1.2 million people with indications for PrEP in 2018, only 18.1 percent had been prescribed PrEP
